| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Mingyue Optical Lens Co Ltd
SZSE:301101
Mingyue Optical Lens Co Ltd
Revenue
Mingyue Optical Lens Co Ltd
Revenue Peer Comparison
1066
603658
300888
300832
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
M
|
Mingyue Optical Lens Co Ltd
SZSE:301101
|
Revenue
¥748.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Revenue
¥13.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Revenue
¥5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Revenue
¥4.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Revenue
¥8.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Revenue
¥3.9B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
See Also
What is Mingyue Optical Lens Co Ltd's Revenue?
Revenue
748.7m
CNY
Based on the financial report for Dec 31, 2023, Mingyue Optical Lens Co Ltd's Revenue amounts to 748.7m CNY.
What is Mingyue Optical Lens Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
8%
Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for Mingyue Optical Lens Co Ltd have been 12% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
